Page last updated: 2024-09-05

sorafenib and l 778,123

sorafenib has been researched along with l 778,123 in 1 studies

Compound Research Comparison

Studies
(sorafenib)
Trials
(sorafenib)
Recent Studies (post-2010)
(sorafenib)
Studies
(l 778,123)
Trials
(l 778,123)
Recent Studies (post-2010) (l 778,123)
6,5207305,2511505

Protein Interaction Comparison

ProteinTaxonomysorafenib (IC50)l 778,123 (IC50)
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaBos taurus (cattle)0.0485
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaHomo sapiens (human)0.3319
Protein farnesyltransferase subunit betaBos taurus (cattle)0.0485
Protein farnesyltransferase subunit betaHomo sapiens (human)0.402
Geranylgeranyl transferase type-1 subunit betaHomo sapiens (human)0.0983
Protein farnesyltransferase subunit betaRattus norvegicus (Norway rat)0.0036
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alphaRattus norvegicus (Norway rat)0.0036

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Korzeniecki, C; Priefer, R1

Reviews

1 review(s) available for sorafenib and l 778,123

ArticleYear
Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway.
    European journal of medicinal chemistry, 2021, Feb-05, Volume: 211

    Topics: Humans; Models, Molecular; Molecular Structure; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Signal Transduction

2021